{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:08:20Z","timestamp":1787004500532,"version":"build-2736575974"},"reference-count":26,"publisher":"Portland Press Ltd.","issue":"4","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,8,1]]},"abstract":"<jats:p>The aim of the present study was to verify whether plasma MMPs (matrix metalloproteinases) and TIMPs (tissue inhibitors of MMPs) could be used as potential markers of paraphysiological remodelling in the athlete's heart, and to correlate these matrix parameters with echocardiographic signs of LV (left ventricular) remodelling. Plasma MMP-2 and MMP-9 were measured by zymography, and TIMP-1 and TIMP-2 were measured by ELISA in 42 veteran marathoners with AH (athlete's heart), and in 25 sedentary healthy subjects (CTL). All subjects were submitted to a clinical examination and two-dimensional colour Doppler echocardiography together with the measurement of circulating NT-proBNP (N-terminal pro-B-type natriuretic peptide); GGT (\u03b3-glutamyl transpeptidase) was evaluated as a marker of cardiovascular disease. Veteran athletes had a significant elevation in LV dimensions and calculated LV mass index. Diastolic and systolic functions were normal for both groups. MMP-9 levels were significantly lower in AH than in CTL subjects (56.9\u00b14.3 compared with 119.4\u00b121.5 m-units\/l, P&amp;lt;0.01). There were significant differences in MMP-2 between the two groups, with a down-regulation in the AH subjects (182.5\u00b116.8\u00a0units\/ml in CTL compared with 117.1\u00b19.1\u00a0units\/ml in AH, P&amp;lt;0.01). MMP-2 and MMP-2\/TIMP-2 were inversely correlated with myocardial indices of hypertrophy in AH and CTL subjects. AH and CTL subjects showed similar TIMP values. The results of the present study indicate that MMPs and TIMPs could represent potential biomarkers of adaptive heart remodelling in the athletes. In addition, the inverse correlation of the MMP-2\/TIMP-2 system with echocardiographic signs of myocardial hypertrophy could represent a new diagnostic and prognostic indicator useful in the evaluation of cardiovascular risk in athletes.<\/jats:p>","DOI":"10.1042\/cs20080278","type":"journal-article","created":{"date-parts":[[2009,2,5]],"date-time":"2009-02-05T10:55:33Z","timestamp":1233831333000},"page":"157-164","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Role of matrix metalloproteinases and their tissue inhibitors as potential biomarkers of left ventricular remodelling in the athlete's heart"],"prefix":"10.1042","volume":"117","author":[{"given":"Annamaria","family":"Vianello","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Pisa, Pisa I-56127, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Caponi","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Molecular Diagnostics, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Pisa I-56126, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Franzoni","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Pisa, Pisa I-56127, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Galetta","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Pisa, Pisa I-56127, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Rossi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Pisa, Pisa I-56127, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Taddei","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Pisa, Pisa I-56127, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino","family":"Malvaldi","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Molecular Diagnostics, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Pisa I-56126, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Pietrini","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Molecular Diagnostics, Azienda Ospedaliera Universitaria Pisana, University of Pisa, Pisa I-56126, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino","family":"Santoro","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Pisa, Pisa I-56127, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2009,7,16]]},"reference":[{"key":"2021113010073377300_B1","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1161\/01.CIR.101.3.336","article-title":"The athlete's heart. A meta-analysis of cardiac structure and function","volume":"101","author":"Pluim","year":"2000","journal-title":"Circulation"},{"key":"2021113010073377300_B2","first-page":"373","article-title":"Endurance training and cardial adaptation (athlete's heart)","volume":"29","author":"Dickhuth","year":"2004","journal-title":"Herz"},{"key":"2021113010073377300_B3","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1161\/CIRCULATIONAHA.106.613562","article-title":"The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"2021113010073377300_B4","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJMoa060781","article-title":"Outcome in athletes with marked ECG repolarization abnormalities","volume":"358","author":"Pelliccia","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"2021113010073377300_B5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1440-1681.2007.04585.x","article-title":"Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure","volume":"34","author":"McMullen","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"2021113010073377300_B6","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1365-2362.2003.01187.x","article-title":"Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure","volume":"33","author":"Altieri","year":"2003","journal-title":"Eur. J. Clin. Invest."},{"key":"2021113010073377300_B7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1050-1738(01)00160-8","article-title":"Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction","volume":"12","author":"D'Armiento","year":"2002","journal-title":"Trends Cardiovasc. Med."},{"key":"2021113010073377300_B8","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/01.RES.0000013290.12884.A3","article-title":"Matrix metalloproteinases. Regulation and dysregulation in the failing heart","volume":"90","author":"Spinale","year":"2002","journal-title":"Circ. Res."},{"key":"2021113010073377300_B9","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"2021113010073377300_B10","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/hc0802.104534","article-title":"Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning","volume":"105","author":"Pelliccia","year":"2002","journal-title":"Circulation"},{"key":"2021113010073377300_B11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","article-title":"Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings","volume":"57","author":"Devereux","year":"1986","journal-title":"Am. J. Cardiol."},{"key":"2021113010073377300_B12","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1161\/CIRCULATIONAHA.105.573865","article-title":"Matrix metalloproteinases\/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease","volume":"113","author":"Ahmed","year":"2006","journal-title":"Circulation"},{"key":"2021113010073377300_B13","doi-asserted-by":"crossref","first-page":"H1847","DOI":"10.1152\/ajpheart.00434.2006","article-title":"Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction","volume":"292","author":"Bergman","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113010073377300_B14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/01.CIR.98.2.157","article-title":"Flow regulation of 72-kD collagenase IV (MMP2) after experimental arterial injury","volume":"98","author":"Bassiouny","year":"1998","journal-title":"Circulation"},{"key":"2021113010073377300_B15","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/01.CIR.0000058700.41738.12","article-title":"Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease","volume":"107","author":"Blankenberg","year":"2003","journal-title":"Circulation"},{"key":"2021113010073377300_B16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2796.2007.01861.x","article-title":"Release of protein as well as activity of MMP-9 from unstable atherosclerotic plaques during percutaneous coronary intervention","volume":"262","author":"Robertson","year":"2007","journal-title":"J. Int. Med."},{"key":"2021113010073377300_B17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.atherosclerosis.2005.06.047","article-title":"Endurance training reduces circulating inflammatory markers in persons at risk of coronary events: impact on plaque stabilization?","volume":"186","author":"Niessner","year":"2006","journal-title":"Atherosclerosis"},{"key":"2021113010073377300_B18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ejvs.2007.04.011","article-title":"Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue","volume":"34","author":"Evans","year":"2007","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"key":"2021113010073377300_B19","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s10016-005-0003-7","article-title":"Overexpression of MMP9 and tissue factor in unstable carotid plaques associated with Chlamydia pneumoniae inflammation and apoptosis","volume":"19","author":"Stintzing","year":"2005","journal-title":"Ann. Vasc. Surg."},{"key":"2021113010073377300_B20","doi-asserted-by":"crossref","DOI":"10.1111\/j.1472-8206.2007.00538.x","article-title":"The role of statins in heart failure","volume":"21","author":"Gullestad","year":"2007","journal-title":"Fund. Clin. Pharmacol."},{"key":"2021113010073377300_B21","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1152\/physrev.00012.2007","article-title":"Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function","volume":"87","author":"Spinale","year":"2007","journal-title":"Physiol. Rev."},{"key":"2021113010073377300_B22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1309\/D7QUF0HJMCYYYY5A","article-title":"Measurement of a plasma stroke biomarker panel and cardiac troponin T in marathon runners before and after the 2005 Boston Marathon","volume":"126","author":"Saenz","year":"2006","journal-title":"Am. J. Clin. Pathol."},{"key":"2021113010073377300_B23","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cardfail.2006.05.012","article-title":"Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure","volume":"12","author":"Yan","year":"2006","journal-title":"J. Card. Failure"},{"key":"2021113010073377300_B24","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/S0895-7061(04)00902-1","article-title":"Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension. Relationship to tissue Doppler indices of diastolic relaxation","volume":"17","author":"Tayebjee","year":"2004","journal-title":"Am. J. Hypertens."},{"key":"2021113010073377300_B25","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jacc.2008.04.069","article-title":"Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)","volume":"12","author":"Masson","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113010073377300_B26","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/01.ATV.0000251993.20372.40","article-title":"\u03b3-Glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study","volume":"27","author":"Lee","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/117\/4\/157\/439878\/cs1170157.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/117\/4\/157\/439878\/cs1170157.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T05:09:16Z","timestamp":1638248956000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/117\/4\/157\/68519\/Role-of-matrix-metalloproteinases-and-their-tissue"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,16]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,8,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20080278","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,16]]}}}